Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening
Abstract Osteosarcoma, the most common primary bone cancer in children and adolescents, presents significant challenges, particularly in metastasis and recurrence, resulting in poor survival rates. This study explores the role of PANoptosis—a complex cell death mechanism involving pyroptosis, apopto...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-93167-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850095063881744384 |
|---|---|
| author | Wenrui Zhao Yameng Wang Junchao Zhu Shahrzad Arya Guowen Huang Shengqin Li Qi Chen Xijuan Liu Jinghong Yuan Jingyu Jia |
| author_facet | Wenrui Zhao Yameng Wang Junchao Zhu Shahrzad Arya Guowen Huang Shengqin Li Qi Chen Xijuan Liu Jinghong Yuan Jingyu Jia |
| author_sort | Wenrui Zhao |
| collection | DOAJ |
| description | Abstract Osteosarcoma, the most common primary bone cancer in children and adolescents, presents significant challenges, particularly in metastasis and recurrence, resulting in poor survival rates. This study explores the role of PANoptosis—a complex cell death mechanism involving pyroptosis, apoptosis, and necroptosis—in osteosarcoma by identifying relevant long non-coding RNAs (lncRNAs) and their prognostic significance. Bioinformatics analyses used RNA expression data from the GEO and TARGET databases to identify differentially expressed genes (DEGs) and PANoptosis-related genes (PRGs). Co-expression analysis revealed lncRNAs linked to PRGs, forming a risk prognostic model. Five PRGs and two lncRNAs were significantly associated with prognosis, with the model showing high predictive accuracy (AUC 0.876, 0.787, and 0.794 for 1, 3, and 5 years). Notably, lncRNA AC133552.2 was downregulated in osteosarcoma tissues, correlating with poor survival and reduced immune infiltration. Silencing AC133552.2 promoted cell proliferation and migration, while overexpression inhibited tumor growth and metastasis, confirmed in xenograft models. AC133552.2 emerges as a potential biomarker and therapeutic target, with future research needed to explore its molecular mechanisms and clinical application. |
| format | Article |
| id | doaj-art-0b2545cb8bc34f51aef2c0e92f99ef61 |
| institution | DOAJ |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-0b2545cb8bc34f51aef2c0e92f99ef612025-08-20T02:41:31ZengNature PortfolioScientific Reports2045-23222025-03-0115111610.1038/s41598-025-93167-2Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screeningWenrui Zhao0Yameng Wang1Junchao Zhu2Shahrzad Arya3Guowen Huang4Shengqin Li5Qi Chen6Xijuan Liu7Jinghong Yuan8Jingyu Jia9Department of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Surgery, Cedars-Sinai Medical CenterDepartment of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Obstetrics and Gynecology, First Affiliated Hospital of Nanchang UniversityDepartment of Pediatrics, The Second Affiliated Hospital of Nanchang UniversityDepartment of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityAbstract Osteosarcoma, the most common primary bone cancer in children and adolescents, presents significant challenges, particularly in metastasis and recurrence, resulting in poor survival rates. This study explores the role of PANoptosis—a complex cell death mechanism involving pyroptosis, apoptosis, and necroptosis—in osteosarcoma by identifying relevant long non-coding RNAs (lncRNAs) and their prognostic significance. Bioinformatics analyses used RNA expression data from the GEO and TARGET databases to identify differentially expressed genes (DEGs) and PANoptosis-related genes (PRGs). Co-expression analysis revealed lncRNAs linked to PRGs, forming a risk prognostic model. Five PRGs and two lncRNAs were significantly associated with prognosis, with the model showing high predictive accuracy (AUC 0.876, 0.787, and 0.794 for 1, 3, and 5 years). Notably, lncRNA AC133552.2 was downregulated in osteosarcoma tissues, correlating with poor survival and reduced immune infiltration. Silencing AC133552.2 promoted cell proliferation and migration, while overexpression inhibited tumor growth and metastasis, confirmed in xenograft models. AC133552.2 emerges as a potential biomarker and therapeutic target, with future research needed to explore its molecular mechanisms and clinical application.https://doi.org/10.1038/s41598-025-93167-2OsteosarcomaPANoptosisLong non-coding RNAAC133552.2Therapeutic target |
| spellingShingle | Wenrui Zhao Yameng Wang Junchao Zhu Shahrzad Arya Guowen Huang Shengqin Li Qi Chen Xijuan Liu Jinghong Yuan Jingyu Jia Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening Scientific Reports Osteosarcoma PANoptosis Long non-coding RNA AC133552.2 Therapeutic target |
| title | Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening |
| title_full | Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening |
| title_fullStr | Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening |
| title_full_unstemmed | Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening |
| title_short | Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening |
| title_sort | long non coding rna ac133552 2 biomarker and therapeutic target in osteosarcoma via panoptosis gene screening |
| topic | Osteosarcoma PANoptosis Long non-coding RNA AC133552.2 Therapeutic target |
| url | https://doi.org/10.1038/s41598-025-93167-2 |
| work_keys_str_mv | AT wenruizhao longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT yamengwang longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT junchaozhu longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT shahrzadarya longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT guowenhuang longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT shengqinli longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT qichen longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT xijuanliu longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT jinghongyuan longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening AT jingyujia longnoncodingrnaac1335522biomarkerandtherapeutictargetinosteosarcomaviapanoptosisgenescreening |